Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 32.95
+0.05 (0.15%)
May 13, 2025, 1:30 PM CST
Synmosa Biopharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 684.68 | 594.83 | 799.09 | 303.86 | 638.11 | Upgrade
|
| Depreciation & Amortization | 335.41 | 334.83 | 315.64 | 297.29 | 296.7 | Upgrade
|
| Other Amortization | 6.56 | 5.09 | 4.74 | 4.77 | 5.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.44 | -0.12 | -281.43 | -11.86 | -0.68 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.24 | 10.86 | 15.22 | 8.21 | 44.32 | Upgrade
|
| Loss (Gain) From Sale of Investments | 63.83 | -49.82 | -50.41 | -4.75 | -233.52 | Upgrade
|
| Loss (Gain) on Equity Investments | 13.78 | 10.33 | 16.56 | 16.4 | 1.54 | Upgrade
|
| Stock-Based Compensation | 14.64 | 17.21 | 22.47 | 10.64 | 4.3 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.49 | 6.74 | 3.41 | 1.82 | 9.94 | Upgrade
|
| Other Operating Activities | -188.89 | -98.04 | -59.33 | -147.25 | -275.64 | Upgrade
|
| Change in Accounts Receivable | -130.66 | -27.87 | -244.16 | -77.74 | -13.62 | Upgrade
|
| Change in Inventory | -110.39 | -305.39 | -120.94 | 16.87 | -172.66 | Upgrade
|
| Change in Accounts Payable | 47.31 | -8.09 | 147.95 | 65.26 | -114.81 | Upgrade
|
| Change in Unearned Revenue | -5.39 | 1.21 | 46.36 | -2.44 | -1.85 | Upgrade
|
| Change in Other Net Operating Assets | 49.55 | 20.15 | 15.08 | -26.21 | 51.51 | Upgrade
|
| Operating Cash Flow | 780.62 | 511.93 | 630.25 | 454.86 | 254.4 | Upgrade
|
| Operating Cash Flow Growth | 52.49% | -18.77% | 38.56% | 78.80% | - | Upgrade
|
| Capital Expenditures | -214.52 | -207.04 | -129.3 | -93.06 | -154.41 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.13 | 1.62 | 305.18 | 240.57 | 9.65 | Upgrade
|
| Cash Acquisitions | - | -48.83 | -95.86 | -7.52 | 82.91 | Upgrade
|
| Sale (Purchase) of Intangibles | -55.13 | -53.48 | -55.03 | -49.07 | -22.8 | Upgrade
|
| Investment in Securities | -105.94 | -402.88 | -96.92 | -2.12 | 90.55 | Upgrade
|
| Other Investing Activities | 35.66 | -7.25 | 2.59 | -15.48 | 28.59 | Upgrade
|
| Investing Cash Flow | -336.8 | -717.87 | -69.33 | 73.33 | 34.5 | Upgrade
|
| Short-Term Debt Issued | 13.62 | 127.07 | - | 133 | - | Upgrade
|
| Long-Term Debt Issued | 159.01 | 493 | 350 | - | 1,683 | Upgrade
|
| Total Debt Issued | 172.62 | 620.07 | 350 | 133 | 1,683 | Upgrade
|
| Short-Term Debt Repaid | - | -50 | -179.76 | - | -756 | Upgrade
|
| Long-Term Debt Repaid | -72.09 | -1,532 | -344.65 | -381.84 | -892.37 | Upgrade
|
| Total Debt Repaid | -72.09 | -1,582 | -524.41 | -381.84 | -1,648 | Upgrade
|
| Net Debt Issued (Repaid) | 100.54 | -962.15 | -174.41 | -248.84 | 35.05 | Upgrade
|
| Issuance of Common Stock | - | 950 | 40.23 | 0.61 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -108.97 | -51.64 | - | Upgrade
|
| Common Dividends Paid | -228.74 | -194.43 | -148.64 | -79.98 | -45.7 | Upgrade
|
| Other Financing Activities | -59.35 | 243.83 | 43.84 | 82.28 | -101.14 | Upgrade
|
| Financing Cash Flow | -187.55 | 37.24 | -347.95 | -297.57 | -111.78 | Upgrade
|
| Foreign Exchange Rate Adjustments | 11.27 | -0.39 | 6.52 | -0.81 | -3.88 | Upgrade
|
| Net Cash Flow | 267.55 | -169.09 | 219.48 | 229.82 | 173.24 | Upgrade
|
| Free Cash Flow | 566.1 | 304.89 | 500.95 | 361.81 | 100 | Upgrade
|
| Free Cash Flow Growth | 85.68% | -39.14% | 38.46% | 261.83% | - | Upgrade
|
| Free Cash Flow Margin | 10.20% | 5.93% | 11.42% | 11.18% | 3.29% | Upgrade
|
| Free Cash Flow Per Share | 1.34 | 0.75 | 1.28 | 0.92 | 0.26 | Upgrade
|
| Cash Interest Paid | 60.02 | 66.97 | 59.29 | 51.82 | 53.42 | Upgrade
|
| Cash Income Tax Paid | - | 5.52 | 69.76 | 65.01 | 9.63 | Upgrade
|
| Levered Free Cash Flow | 426.14 | 148.45 | 362.14 | 420.14 | -282.46 | Upgrade
|
| Unlevered Free Cash Flow | 462.45 | 190.44 | 399.33 | 452.62 | -249.45 | Upgrade
|
| Change in Net Working Capital | 87.61 | 291.68 | 47.14 | -165.34 | 472.14 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.